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Abstract
Background: Stigma refers to a distinguishing personal trait that is perceived as or actually is physically, socially,
or psychologically disadvantageous. Little is known about the opinion of those who have more or less stigmatizing
health conditions regarding the need for consent for use of their personal information for health research.
Methods: We surveyed the opinions of people 18 years and older with seven health conditions. Participants
were drawn from: physicians' offices and clinics in southern Ontario; and from a cross-Canada marketing panel
of individuals with the target health conditions. For each of five research scenarios presented, respondents chose
one of five consent choices: (1) no need for me to know; (2) notice with opt-out; (3) broad opt-in; (4) project-
specific permission; and (5) this information should not be used. Consent choices were regressed onto:
demographics; health condition; and attitude measures of privacy, disclosure concern, and the benefits of health
research. We conducted focus groups to discuss possible reasons for observed consent choices.
Results: We observed substantial variation in the control that people wish to have over use of their personal
information for research. However, consent choice profiles were similar across health conditions, possibly due
to sampling bias. Research involving profit or requiring linkage of health information with income, education, or
occupation were associated with more restrictive consent choices. People were more willing to link their health
information with biological samples than with information about their income, occupation, or education.
Conclusions: The heterogeneity in consent choices suggests individuals should be offered some choice in use of
their information for different types of health research, even if limited to selectively opting-out. Some of the
implementation challenges could be designed into the interoperable electronic health record. However, many
questions remain, including how best to capture the opinions of those who are more privacy sensitive.
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Background
The term "stigma" generally refers to a distinguishing per-
sonal trait that is perceived as or actually is physically,
socially, or psychologically disadvantageous. [1] Because
of the presence of that trait, an individual may be discrim-
inated against – e.g. in employment or in social circles.
Health conditions will vary in the extent to which they are
perceived by those individuals having the condition and
by others as being stigmatizing. Individuals with a poten-
tially stigmatizing health condition may be more inclined
than members of the public without such conditions to
experience concerns over disclosure of their personal
health information out of concern that this could result in
discrimination against them. For example, a person with
a prior history of cancer may be concerned over denial of
certain employment opportunities, a mortgage, or life
insurance. A person with HIV/AIDS may be concerned
about social isolation because of others' concerns that
their presence puts others at increased risk of contracting
the condition.
There is now an emerging body of literature examining
the opinion of the public regarding consent for use of
one's health information for research. [2-9] However, the
opinion of those who have health conditions that may be
stigmatizing to a greater or lesser degree has been much
less studied. [10] There are several reasons for considering
– or even giving priority to – the values and expectations
of these individuals. People who are unwell have the most
at stake, both because they stand to benefit from research
into their health condition and because a breach of pri-
vacy may potentially expose them to discrimination in
obtaining loans, mortgages, insurance, or employment.
Moreover, they are under-represented in surveys targeted
to the general public and, to the extent that some health
conditions are stigmatizing, the perspective of individuals
with these conditions may be discounted by the general
public. Further, if we listen only to the voice of the general
public without attention to the concerns of this vulnera-
ble minority we run the risk of committing a form of "tyr-
anny of the majority". [11]
Objective
The purpose of this study was to examine the attitudes of
people with a range of potentially stigmatizing health
conditions concerning the need for consent for the use of
their personal information for different types of observa-
tional health research, and to compare their attitudes with
those of the general public. We hypothesized that:
- responses would differ across health conditions;
- some patient groups would be more permissive and oth-
ers more restrictive than the general public; and
- people's view of the level of consent required for use of
their information would vary directly with disclosure con-
cern and inversely with perceptions of the benefits of
health care and the potential for health research to
improve the lifespan and quality of life of people with
their health condition.
This paper reports on the testing of these hypotheses.
Methods
Choice of health conditions
In this study, we included seven health conditions with
varying susceptibility to being labelled as stigmatizing.
Four conditions – hypertension, diabetes, chronic depres-
sion and alcoholism – were used in a previous public
opinion survey of members of the public, in which
respondents were asked to imagine they had one of these
health conditions. [4] In the previous study, hypertension
and diabetes were found to be lower-stigma health condi-
tions. Chronic depression and alcoholism were found to
be higher-stigma conditions. In this study, we had the
opportunity to obtain the views of people with these con-
ditions. To these four conditions we added: HIV, to create
an upper extreme category for potential stigma; breast
cancer; and lung cancer. We anticipated that responses
may differ between breast and lung cancer because of a
greater general public support for breast cancer sufferers
and a perception that lung cancer is self-inflicted through
smoking.
Survey
The study proceeded in two phases. In Phase 1 (Novem-
ber 2006 to July 2007), we surveyed individuals with the
target health conditions. In Phase 2 (July to September
2007), we held focus groups with a sub-sample of partici-
pants from Phase 1 – one group for each health condition.
The chief purpose of Phase 2 was to help inform our anal-
ysis of the findings derived from Phase 1, by providing
examples of the types of concerns some people took into
account when making decisions around consent.
Setting and Participants
Survey participants were drawn from two sources: (1) a
pre-existing cross-Canada panel of individuals with iden-
tified health conditions, maintained by Harris Interactive,
a professional polling firm; and (2) patients recruited by
the investigators through family physicians' offices and
specialty clinics in the vicinity of Hamilton, Ontario, Can-
ada. The reference group consisted of people recruited
through Harris Interactive who had none of the target
health conditions and no other serious health conditions.
This group was used to approximate the response of the
general public. All survey participants were 18 years or
older.BMC Medical Ethics 2009, 10:10 http://www.biomedcentral.com/1472-6939/10/10
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Participants recruited directly by the investigators were
either sent a letter from the physician's office in the mail
explaining the study or handed an information brochure
in the clinic by staff. In each case, information was pro-
vided for patients to contact the investigators if interested.
In total, 892 brochures were mailed to patients' homes
and 888 brochures provided to physicians and clinics for
directly handing out to patients.
All participants recruited through Harris Interactive com-
pleted the survey over the internet. Participants recruited
through local family physicians and clinics were given the
choice to complete the survey via internet or by telephone.
This was done to minimize refusal due to lack of access to
or familiarity with the internet, particularly among older
patients. Those opting to do the internet survey used the
same system as the Harris participants. Those opting to
complete the survey by telephone arranged a scheduled
call with telephone surveyors from Harris Interactive.
They were mailed a hard copy of the core questions of the
survey beforehand, so as to minimize differences in
response due to method of survey administration.
Sample size was calculated on the basis of the primary
outcome variable – consent choice in the use of personal
information for health research. This was expressed on a
5-point ordinal scale. (See Survey Data and Key Variables
below.) This sample was determined with the primary
goal of building a multivariable regression model to com-
pare the overall attitudes among the seven groups and the
general public controlling for several demographic and
other confounding variables. Heuristics based on simula-
tion studies indicate that at least five respondents per
degree of freedom for each predictor variable are required
for the stability of the model. [12] We have 7 predictor
variables with a total of 21 degrees of freedom, which
would require at least 105 participants. We aimed to
recruit 1400 and obtained responses from 1137 (734
from Harris Interactive and 403 from physician offices
and clinics) with the sampling stratified by health condi-
tion. We inflated our minimum sample size by a factor of
over 10 to account for potential clustering of responses
within a patient. Therefore, the sample size was adequate
to ensure the stability of the model.
Survey Data and Key Variables
We collected information on participant demographics,
attitudes about privacy, disclosure concern, and the bene-
fits of health care and health research at improving lon-
gevity and quality of life, and the participant's health
conditions. Where the participant had more than one tar-
get health condition, they were asked to answer the survey
questions with only one health condition in mind. In ear-
lier pilot work, we established an algorithm for determin-
ing which health condition would take priority, ranking
the 7 health conditions according to level of disclosure
concern. This algorithm placed HIV/AIDS first, followed
by alcoholism, lung cancer, breast cancer, depression, dia-
betes and hypertension.
We presented five different scenarios involving use or
linkage of personal information for health research: (1)
use of health data for quality improvement; (2) use of the
same data for marketing; (3) linkage of work/education/
income information with health information; (4) linkage
of biosamples with health information (a) assuming no
profit and (b) assuming a profit element. (See additional
file 1 for a more detailed description.) These scenarios
were identical to those used two years earlier in a series of
seven cross-Canada public dialogues. [13] Participants of
the current study were advised that, in each scenario,
names, addresses and any other information that could
directly identify them were removed. Following each sce-
nario, participants were asked which statement best
described their view (words in italics not included in sur-
vey responses):
(1) There is no need for me to know. Just use it.
(2) My permission is not needed, but I want to know
this is being done and a chance to say "no." [i.e. notice
with opt-out]
(3) My general permission is needed. This could be for
several different research studies. I could withdraw my
permission in future. [i.e. broad opt-in]
(4) My permission is needed each time. [i.e. project-
specific consent]
(5) My information should not be used for this pur-
pose.
The five response options above, hereinafter referred to as
"consent choices", served as the outcome variable in a
multivariable regression analysis using the following as
predictor variables:
- demographics (age, sex, education, marital status,
employment, and income)
- health condition (one of the 7 target conditions)
- self-reported health (6-point scale, varying from
"very poor" to "excellent")
- scenario, and
- attitudinal variables (disclosure concern and medical
benefits score. These are described below. QuestionsBMC Medical Ethics 2009, 10:10 http://www.biomedcentral.com/1472-6939/10/10
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used to compile these scores and the scoring scheme
are found in additional file 2.)
While there are many dimensions to stigma, for the pur-
poses of this study, we chose to focus on individuals' dis-
closure concern – i.e. concern that others may find out
about their health condition. For this, we asked: How con-
cerned would you be if: (a) your employer found out
about any health condition(s) you have; (b) your health
insurer found out about any health condition(s) you
have; or (c) a friend other than those you told found out
about any health conditions you have. For each of these
questions, respondents replied either: "not at all con-
cerned"; "somewhat concerned"; or "very concerned".
For the medical benefits scale, people replied on a 5-point
scale ("strongly agree, somewhat agree", "neither agree
nor disagree", "somewhat disagree", or "strongly disa-
gree") to the following statements: (a) Medical treatments
can improve the quality of my life; (b) medical treatments
can extend my life; (c) disease prevention programs have
shown me how to live a healthier life; and (d) medical
research can improve my life.
We re-scaled the disclosure concern and medical benefits
scores to a 0–1 scale to facilitate interpretation of relative
attitudes toward disclosure and medical benefit across
health conditions.
Dealing with potential sampling bias
We checked for sampling bias chiefly through two meth-
ods. Harris Interactive sampled questions from our survey
in an omnibus random-digit dialled telephone survey and
compared the responses from the telephone survey with
those from their internet sample. In addition, we com-
pared the consent choices of the reference group from this
study regarding the five scenarios with the consent choices
of the people who participated in the public dialogues in
our previous study. [13]
Statistical methods
Consent choices were analysed graphically across scenar-
ios and across health conditions. We also plotted disclo-
sure concern and medical benefit scores across health
conditions using a radar graph.
To test our chief hypotheses, we used regression analysis
controlling the correlation across scenarios using the
method of generalized estimating equations (GEE)
assuming an exchangeable correlation structure. [14] The
results are reported as estimates of model coefficients
(with corresponding 95% confidence interval) and associ-
ated p-value. Statistical computations used SAS, version
9.1.3 (Cary, NC.). In earlier work, we found the results of
linear regression to yield equivalent results to multino-
mial logistic regression which is the more correct analysis
but more difficult to interpret. [4]
Initially, individual predictor variables were regressed
onto consent choice using univarite analysis. Variables
that met the criterion of alpha = 0.20 were then included
in the multivariable regression model. The chief variables
of interest – health condition, disclosure concern, and
medical benefit scores – were forced into the model. We
tested for interaction effects of disclosure concern and
medical benefits scores with research scenarios and health
condition, No significant interactions were found.
Focus Groups
At the end of the survey, those participants recruited
directly by the investigators in the Hamilton area were
asked if they would be willing to participate in a focus
group to discuss the reasoning that participants may have
used to make their consent choices. Those who agreed
were contacted by the study coordinator. One focus group
was convened for each health condition except for alco-
holism, as the survey sample size was too small for this
group. We sampled from the pool of survey participants to
provide a representative sample in each focus group with
regard to age, gender, and self-reported health status.
When making selections, investigators were blind as to
volunteers' responses to survey questions.
Six focus groups, ranging in size from 6 to 10 individuals,
were conducted between July and September 2007. Focus
groups were 90 minutes in length. Participants received an
honorarium of $75 following the session. These meetings
were moderated by two of the researchers. Upon arrival,
participants completed a mini-survey comprised of the
key questions from the Phase 1 survey. During the focus
group, a structured interview protocol was used to ask par-
ticipants to reflect on the survey findings regarding con-
sent choice for the five different research scenarios.
Participants were then asked to consider how the survey
responses compared with their own responses and to con-
sider the reasons for their responses and any possible var-
iance from the response pattern from the Phase 1 survey.
Focus group participants were also asked to comment on
the relative importance of individual control over use of
their information and safeguards and the relation
between them. This question was addressed both in the
abstract and by giving them the opportunity to rate spe-
cific controls and safeguards. Immediately following the
meeting, participants again completed the mini-survey, so
a comparison of the responses of focus group participants
with those of the larger sample could be made. Discus-
sions were audio recorded and transcribed for analysis.
Verbatim transcripts from all focus groups were read inde-
pendently by at least two members of the research teamBMC Medical Ethics 2009, 10:10 http://www.biomedcentral.com/1472-6939/10/10
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and quotations were selected to exemplify the types of rea-
soning that focus group participants used to make their
consent choices. These quotations are used below to help
illustrate the broader survey analysis, and to provide a
window on the kinds of issues some people may address
when making consent choices.
Ethics Review
The research was reviewed and approved by the research
ethics boards of St. Joseph's Healthcare, Hamilton,
Ontario, McMaster University Health Sciences REB, Ham-
ilton, Ontario and the Social Sciences and Humanities
REB, University of Ottawa, Ottawa, Ontario.
Results
Participants
Four hundred three survey participants were recruited
directly by the investigators and 734 were recruited
through Harris Interactive. Recruitment of survey partici-
pants through the investigators' sources is summarized in
Figure 1.
Demographic data
Additional file 3 summarizes the demographic character-
istics of study participants by sampling source. Those
recruited directly by the investigators are presented by
method of survey completion. Overall, the reference
group was younger (mean age 46 years) than participants
with target health conditions (mean 55 years), regardless
of sampling source. Their self-reported health was better
than those with the target health conditions. Those with
the target health conditions completing the survey over
the internet were comparable between the two sampling
sources on most demographic variables. However, the
Harris sample was less wealthy and reported poorer
health than the sample assembled by the investigators.
Survey participants recruited by the investigators who
completed the survey by telephone were older (mean age
Summary of recruitment process, using the investigators' sample Figure 1
Summary of recruitment process, using the investigators' sample.BMC Medical Ethics 2009, 10:10 http://www.biomedcentral.com/1472-6939/10/10
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62) with a greater percentage of women (68% vs. 60% in
general public and 53% and 57% in the Harris and inves-
tigator internet samples). Telephone survey participants
had a greater percentage with high school education or
less (56%) than those who completed the survey over the
internet (28%). In addition, telephone respondents were
more likely to be separated, widowed, or divorced (30%
vs. 14–24%). Fewer were employed (21% vs. 49–72%)
and a greater percent had an income less than $40,000 per
year (42% vs. 20–35%).
Attitudes
A summary score of participants' perceptions about the
benefits to be accrued from health care and health
research (medical benefits score) and disclosure concern
is provided in Figure 2. Each axis on this radar plot repre-
sents one health condition or the reference group. The
scale on the axis for both attitudes was standardized to
(0,1) to facilitate comparison. The medical benefits score
was uniformly high across health conditions. On the
other hand, there was substantial variation across the
health conditions regarding the level of concern partici-
pants had about employers, insurers, or friends finding
out about their health condition. Disclosure concern was
lowest for those with hypertension, diabetes, and lung
cancer. It was highest among those with chronic depres-
sion and HIV/AIDS. We note also that disclosure concern
in the reference group was almost as high as the HIV/AIDS
group yet, they had no serious or chronic health condi-
tion.
Consent choice
Across scenarios, consent choice profiles were very similar
for all health conditions. They were also very similar to
the profile of the reference group. For ease of presentation,
we have combined the responses across health conditions
in Figure 3 and compared these with the reference group.
Attitudes of survey participants across health conditions Figure 2
Attitudes of survey participants across health conditions.
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Effect of intended use and commercialization on consent choice
Scenario 1 involved the use of prescribing information
from the medical record for quality improvement and, for
this paper, serves as the comparator scenario. Figure 3
shows a relatively permissive consent profile for this sce-
nario, with the most common response being "Just use it"
(35–40%). By contrast Scenario 2, which used the same
prescribing information for marketing purposes, elicited
essentially the opposite profile, with over 40% of
respondents indicating that this information should not
be used (at all) for this purpose.
A similar, though less marked, shift in the pattern of con-
sent choice was observed when comparing Scenarios 4a
and 4b. In Scenario 4a, individuals' health information
was linked with biological samples in the absence of any
commercialization of any discovery. In this case, the con-
sent profile was quite similar to that for Scenario 1. When
a potential profit element was introduced through the
development of a commercial lab test (Scenario 4b), the
consent profile displayed a desire for greater control over
use of that information, though not as strong as for the
marketing scenario (Scenario 2), and with no particular
consent choice being preferred.
In our focus groups, we probed for explanations behind
the desire for greater control when commercialization was
involved. The responses were wide ranging. A common
sentiment was that people felt they were being taken
advantage of:
"It was a matter of control. It's the whole idea of profit, that
word 'profit'. Once I see that, I just have a sense of being
taken advantage of. ... but on the other hand I wouldn't not
do it because it is helpful. I would just want to know." (Par-
ticipant 7, Diabetes group)
"First thing I thought of was 'Well, if they're selling it for a
profit what do I get out this?' I just don't see your volunteer-
ing something, if somebody else is making a profit out of it.
I don't see that." (Participant 3, Lung cancer group)
Consent choices across research scenarios – A comparison of the general population with a pooled sample of those with the  target health conditions Figure 3
Consent choices across research scenarios – A comparison of the general population with a pooled sample of 
those with the target health conditions.BMC Medical Ethics 2009, 10:10 http://www.biomedcentral.com/1472-6939/10/10
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Different consent profiles for linkage with biological samples vs. 
income, education, and occupation, in the absence of profit
The consent profile for linkage of health information with
biological samples in the absence of profit (Scenario 4a)
was similar to that for the quality improvement scenario
(Scenario 1). Thirty to 40% of respondents felt it was
acceptable to link this information without notification.
By contrast, linkage of health information with income,
education, or occupation (Scenario 3) was associated with
a consent profile that reflected a desire for greater control
over use of the information. For this scenario, only 11–
15% felt it was acceptable to link this information without
notification and 30–43% of respondents felt their consent
should be sought for each use before the information
could be linked.
Because this finding surprised us, we probed this in our
focus groups. Similar sentiments were expressed across
groups, around 3 categories of explanations:
1. Participants felt that information about income,
education or occupation says a lot about "who we are"
whereas a biosample only provides information about
"what we are".
"I think the simple answer is that physical tissue sample
is just a piece of what you are, what you might
be...where the rest of the information [education,
income, and employment] is more of who you are. Peo-
ple are more afraid of the revelation of who you are
than what you are." (Participant 8, HIV group)
2. Participants believed that access to information
about education, income, and occupation can lead to
the identification of the individual, but biosamples
cannot.
"The work, education and your income. If somebody
looks at a biological sample they can't look up and say
'That's you or you.' You can identify somebody by all
that, those other things." (Participant 6, Depression
group)
"The only thing you can get from tissue or bodily fluids
is DNA and what the disease is. They can't get infor-
mation about you per say. Right?" (Participant 3,
Lung cancer group)
3. Participants trusted that their doctor and the medi-
cal system will ensure that the information will be
used appropriately.
"I think with tissue you can see a real concrete connec-
tion. You can imagine a scientist in a lab studying that
tissue, looking for an answer. With income and work
you're not sure what types of people are analyzing that.
It's not a white lab coat, microscope it's more of a psy-
chological marketing." (Participant 7, Depression)
"I trust giving out the information to most of the medi-
cal profession but it's not something I would give will-
ingly to people that I don't really know well."
(Participant 3, Depression)
"I have found when I've been asked to [do] this that my
family Doctor, where I go – and I have trust in him and
in his staff – and he sent a letter saying 'This is what
they are asking you to do and I believe in it.' And so I
feel that gave me the confidence that this wasn't just
some little thing that showed up at my door. My family
doctor... I have trust in him." (Participant 8, Diabe-
tes)
These (and other) references to high trust were directed
more toward doctors and hospitals or, even more person-
ally, to their doctor. While there was also a relatively high
trust toward university researchers (Figure 4), that trust
was more tentative than for doctors.
Regression analyses
Additional file 4 compares three regression models. The
full model examines the independent contributions of
health condition and attitudes toward disclosure concern
and medical benefits, controlling for scenario, survey
method, and sex. Reduced model 1 removes disclosure
concern and medical benefit from the model while
reduced model 2 removes health condition from the
model.
In the full model, consent choices among survey partici-
pants did not differ significantly across health conditions,
compared with the reference group. Increased disclosure
concern was associated with a more restrictive consent
choice while greater perception of the benefits of medical
care and medical research was associated with more per-
missive consent choice. When the attitude variables (dis-
closure concern and medical benefits scores) were
removed from the model (Reduced Model 1), the coeffi-
cients for several of the health conditions moved in the
direction of being more permissive compared with the ref-
erence group. In two cases (breast cancer and hyperten-
sion) these became statistically significant. On the other
hand, when health conditions were removed from the
model (Reduced Model 2), estimates for the attitude vari-
ables were s . This suggests that the stronger predictor of
consent choice was individual attitude toward medical
benefit and disclosure concern than was the person's
health condition.BMC Medical Ethics 2009, 10:10 http://www.biomedcentral.com/1472-6939/10/10
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Regression results also confirm our perceptions that
research involving an element of profit (Scenarios 2 and
4b) or requiring linkage of health information with
income, education, or occupation (Scenario 3) were asso-
ciated with more restrictive consent choices. Female
respondents were also generally more restrictive in their
consent choices. Those completing the survey by tele-
phone were more permissive in their consent choices than
were those completing the survey over the internet.
Discussion
Chief findings
We had hypothesized that consent choice would differ
across the selected health conditions and also with indi-
vidual attitudes regarding disclosure concern and percep-
tions of the benefits of medical care and research. While
we recognized beforehand that hypertension and diabetes
were relatively low in stigma and that HIV and alcoholism
were likely higher in stigma, we did not assume strict ordi-
nality across health conditions. We found that, collec-
tively, participants with target health conditions were
slightly more permissive in their consent choices com-
pared against the reference group (Figure 3). However,
when we controlled for survey method, sex, and attitudes,
we found no statistically significant difference in consent
choice across health conditions, compared with our refer-
ence group – this despite having chosen health conditions
that differed widely in potential for stigma. When exam-
ining the confidence intervals around the parameter esti-
mates for the health conditions, they did not appear to be
of a magnitude that would be policy relevant. These find-
ings surprised us. It may be that, across health conditions,
those who were more privacy sensitive were less inclined
to participate in the study and those were more permissive
about use of their information were more inclined to par-
ticipate. This is discussed further under "Limitations"
below.
Disclosure concern differed across health conditions and
was associated with more restrictive consent choices. By
contrast, there was a uniformly high rating of medical
benefits across health conditions. However, at the individ-
ual level, a lower perception of medical benefits was asso-
ciated with more restrictive consent choices. Thus,
individual attitudes – and disclosure concern in particular
– were more predictive of consent choice than was one's
health condition. This suggests that privacy attitudes may
be formulated relatively early on and may be robust to
one's health condition, which may develop later in life.
We also observed significantly more restrictive consent
choices in research scenarios involving profit or when
linking health information with income, education, or
occupation. This is consistent with findings from our ear-
Trust in organizations Figure 4
Trust in organizations.
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lier public dialogues. [13] We also note that people were
relatively trusting with regard to linking their health
records to their biological samples – even more trusting
than with linking to income, education, and occupation.
This is an interesting finding worthy of further study,
given that there is a much higher likelihood of commer-
cial application and intellectual property protection in
research involving biological samples and the great poten-
tial for stigmatization and discrimination. Our focus
groups suggest that, at least in part, their lesser concern
was attributable to perceptions that specialized knowl-
edge was required to interpret one's DNA and those with
that specialized knowledge were trusted to keep the infor-
mation confidential. However, once one's genetic risk
profile is recorded in the health record, this information is
equally subject to misadventure as one's income, should
that information fall into the wrong hands. With regard to
trust, we note that most of the focus group discussion of
trust was in reference to their doctors. Perhaps trust in
one's doctor then confers benefits of trust to the research-
ers in the process.
Limitations
Based on a comparison with a subset of questions in an
omnibus survey conducted by Harris Interactive, we deter-
mined that people recruited into the study were some-
what less privacy concerned and more research-friendly
than the general public. Within our study sample, those
who completed the survey by telephone were particularly
less privacy concerned. This observation is reinforced by
comparison of our current findings with those of our ear-
lier study involving a cross-Canada sample of the general
public using random-digit dialling. In the earlier study,
the profiling of consent choices was somewhat less per-
missive than observed here – particularly around the link-
age with genetic information. [13] Intuitively, one would
expect that individuals willing to participate in ongoing
internet consumer panels may be less privacy concerned
and more open to participating in research. Our conven-
tional sampling through clinics, though, was also subject
to a similar selection bias. Current ethics rules require that
a researcher not approach potential research participants
directly, based on prior knowledge about that individual's
health condition. Individuals must first be asked by some-
one who may be reasonably expected to have access to
this information if they would be willing to have their
name released so they could be called by the researcher, or
if they would be willing to take the initiative themselves
to contact the researcher. This two-stage process probably
resulted in lack of access to more privacy-sensitive
research participants.
The reference group in this study is not quite representa-
tive of the "general public", to the extent that: (a) they,
too, were drawn from the Harris internet polling sampling
frame; and (b) they consisted of individuals who did not
have any of the target health conditions and who had no
other major health conditions. A true random sample of
the public would have some proportion of respondents
with the target health conditions.
Given all this, we believe our study may have under-rep-
resented those in our society who are the most privacy
sensitive. Moreover, depending on the severity of the
selection bias, it may be that our failure to observe a dif-
ference in consent choice across health conditions may be
a result of the absence of more privacy-sensitive respond-
ents. These non-participants may represent varying pro-
portions across health conditions. We cannot assess what
proportion of the selection bias is due to self-selection or
selective approaching by their physicians.
Finally, in the consumer literature, stated privacy prefer-
ences are often much more stringent than those revealed
in actual behaviour. [15] Thus, it is possible that the stated
consent choices for use of one's personal information
reported here may be different than what they are pre-
pared to accept in the health care "marketplace".
Policy implications
No one consent option was preferred by even a simple
majority of survey participants in any of the scenarios
(Figure 3). This wide variation in opinion is consistent
with our earlier work with the general public and with a
recent American survey. [3] This high heterogeneity in
consent choices makes it difficult to put forward any one
model for consent for research use of one's personal
health information. One possible response would be to
offer individuals a menu of choices with a mechanism to
track their choices re: secondary uses of data. While this is
now technically possible, there are multiple challenges
from a systems perspective. For example, who would bro-
ker the consent process and under what conditions? Anec-
dotal evidence suggests that physicians do not have the
time for this. On the other hand, special "clinics" could be
set up through hospitals and centres where applications
are made for renewal of health cards. Information could
be available through brochures and DVDs, and knowl-
edgeable individuals could be available either in person
or over the telephone. All these approaches would require
a substantial investment in funds and an ongoing infra-
structure for managing these consent choices. This could
also be designed into the planned pan-Canadian interop-
erable electronic health record system, through secure
web-based patient portals into their health record. [16,17]
These portals are web-based interactive systems that allow
individuals to view their health record and communicate
in a secure fashion with their health care provider's office.
Another consideration is whether consent choices should
be totally unconstrained. There is growing evidence thatBMC Medical Ethics 2009, 10:10 http://www.biomedcentral.com/1472-6939/10/10
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opt-in consent processes can result in selection biases that
may affect conclusions as to various causal associations.
[18] Are there certain types of research (e.g. public health,
quality of care) for which the default assumption would
be that the information may be used for research and peo-
ple's only option would be to selectively opt out? These
are but two examples of issues that need to be addressed
through further research.
Our survey and focus group participants placed high trust
in medical researchers – higher than that found recently
by Westin in the United States. [3] However, as in Westin's
study, much of this trust was qualified. Approximately
two-thirds of those expressing trust in university research-
ers only "somewhat trusted" them. Therefore, much of
this trust in researchers is vulnerable to erosion in the
event of a high-profile breach of confidence. Survey par-
ticipants also valued highly the ability to monitor how
their information was being used and the ability to say
"No" to particular uses. This "trust but verify" attitude
could also be accommodated through the development of
a patient portal into one's electronic health record.
We observed a shift toward more restrictive consent
choices when research involved a commercial element.
Given the increasing importance of personal information
to health research, and the pervasiveness of the private
sector and commercialization in the research enterprise,
continued public engagement would be worthwhile. This
would help researchers to better appreciate the underlying
concerns of the public around research and profit and to
determine whether these views change or are reinforced
with a better understanding of the role of both personal
information and the private sector in research.
Conclusions
The public is generally supportive of research use of per-
sonal health information, but do not wish to entirely
relinquish control. Despite having a relatively research-
friendly sample, we still observed substantial individual
variation in opinion as to the degree of control that peo-
ple wish to have over use of their personal information for
research. Opportunities for individual choice over use of
one's personal health information could be designed into
the planned pan-Canadian inter-operable electronic
health record system.
People's desire for control over use of their personal
health information increases when there is a commercial
element to the research. Additional public engagement is
required to better understand this.
Finally, this study attempted to address the question of
how much control patients would like over use of their
personal health information for research. While we fully
appreciate the rationale for restricting researchers from
directly recruiting patients on the basis of prior knowledge
about their health condition, it is ironic that, to meet eth-
ical requirements respecting individuals' privacy, this
study has likely under-represented the interests of those
very people whose voices need to be heard. When address-
ing questions like the one we have posed here, there need
to be ways to better reach those who have the most at
stake.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
DW conceived and designed the study, led the focus
groups and the analyses and was the primary author of the
manuscript; VS, CC, LS, JR and LT all contributed to the
development of the protocol. JR led in the analyses of the
text. LT provided statistical guidance. JC conducted the
statistical analyses. All co-authors reviewed and revised
drafts of the manuscript. All authors read and approved
the final manuscript.
Additional material
Additional file 1
Box 1 – Description of Research Scenarios. Provides information about 
the scenarios on which consent choices were made.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1472-
6939-10-10-S1.doc]
Additional file 2
Appendix 1. Survey questions that formed the elements for (a) the dis-
closure concern scale; (b) the medical benefits scale; and (c) the con-
sent choices outcome variable. This document provides the core questions 
that were used in developing two key predictor variables (a measure of 
individuals' concern over disclosure of information about their health con-
dition and a measure of individuals' perceptions of the benefits of health 
care and health research for their health condition) and the key outcome 
variable (consent choice).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1472-
6939-10-10-S2.doc]
Additional file 3
Table 1. Summary of Participant Demographics. This describes basic 
demographic features of survey participants broken down by survey 
method and sample source. We divided investigator sample source into 
those who responded by telephone and internet to determine whether 
demographic characteristics varied more by sample source or self-selected 
method of completion of the survey.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1472-
6939-10-10-S3.doc]Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Medical Ethics 2009, 10:10 http://www.biomedcentral.com/1472-6939/10/10
Page 12 of 12
(page number not for citation purposes)
Acknowledgements
This study was supported by a grant from the Canadian Institutes of Health 
Research (Grant Number MOP-79315).
References
1. Anonymous: Dorland's Illustrated Medical Dictionary 31st edition. Phila-
delphia: Saunders Elesvier; 2007. 
2. Singleton P, Wadsworth M: Consent for the use of personal
medical data in research.  BMJ 2006, 333:255-258.
3. Westin AF: How the public views privacy and health research.
Results of a national survey commissioned by the Institute of Medicine Com-
mittee on "Health research and the privacy of health information: The
HIPPA Privacy Rule" 2007 [http://www.iom.edu/Object.File/Master/48/
528/%20Westin%20IOM%20Srvy%20Rept%2011-1107.pdf].
4. Willison DJ, Schwartz L, Abelson J, Charles C, Swinton M, Northrup
D, Thabane L: Alternatives to project-specific consent for
access to personal information for health research: What is
the opinion of the Canadian public?  Journal of the American Med-
ical Informatics Association 2007, 14:706-712.
5. Kass NE, Natowicz MR, Hull SC, Faden RR, Plantinga L, Gostin LO,
Slutsman J: The use of medical records in research: what do
patients want?  J Law Med Ethics 2003, 31:429-433.
6. Damschroder LJ, Pritts JL, Neblo MA, Kalarickal RJ, Creswell JW,
Hayward RA: Patients, privacy and trust: patients' willingness
to allow researchers to access their medical records.  Soc Sci
Med 2007, 64:223-235.
7. Robling MR, Hood K, Houston H, Pill R, Fay J, Evans HM: Public atti-
tudes towards the use of primary care patient record data in
medical research without consent: a qualitative study.  J Med
Ethics 2004, 30:104-109.
8. Willison DJ, Keshavjee K, Nair K, Goldsmith C, Holbrook AM, for the
COMPETE investigators: Patients' consent preferences for
research uses of information in electronic medical records:
Interview and survey data.  BMJ 2003, 326:373-376.
9. Whiddett R, Hunter I, Engelbrecht J, Handy J: Patients' attitudes
towards sharing their health information.  Int J Med Inform
2006, 75:530-541.
10. Page SA, Mitchell I: Patients' opinions on privacy, consent and
the disclosure of health information for medical research.
Chronic Dis Can 2006, 27:60-67.
11. Tocqueville A: Democracy in America New York, NY: Schocken Books;
1961. 
12. Hair JF Jr, Anderson RE, Tatham RL, Black WC: Multivariate data anal-
ysis 5th edition. Upper Saddle River, New Jersey: Prentice Hall; 1998. 
13. Willison DJ, Swinton M, Schwartz L, Abelson J, Charles C, Northrup
D, et al.: Alternatives to project-specific consent for access to
personal information for health research: insights from a
public dialogue.  BMC Med Ethics 2008, 9(18):.
14. Diggle PJ, Heagerty P, Liang K, Zeger SL: Analysis of Longitudinal Data
2nd edition. Oxford: Oxford University Press; 2002. 
15. Norberg PA, Horne DR: Privacy attitudes and privacy-related
behavior.  Psychology & Marketing 2007, 24:829-847.
16. Grant RW, Wald JS, Poon EG, Schnipper JL, Gandhi TK, Volk LA, Mid-
dleton B: Design and implementation of a web-based patient
portal linked to an ambulatory care electronic health record:
patient gateway for diabetes collaborative care.  Diabetes Tech-
nology & Therapeutics 2006, 8:576-586.
17. Hess R, Bryce CL, Paone S, Fischer G, McTigue KM, Olshansky E,
Zickmund S, Fitzgerald K, Siminerio L: Exploring challenges and
potentials of personal health records in diabetes self-man-
agement: implementation and initial assessment.  Telemedi-
cine Journal & E-Health 2007, 13:509-517.
18. Kho ME, Duffett M, Willison DJ, Cook DJ, Brouwers MC: Written
informed consent and selection bias in observational studies
using medical records: systematic review.  BMJ 2009, 338:b866.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1472-6939/10/10/pre
pub
Additional file 4
Table 2. Regression analysis of consent choice predictors. This table 
presents the results of regression modelling of predictors of consent choice 
– scenario, survey method, health condition, sex, disclosure concern score, 
and medical benefits score. The latter two variables were a composite of 
several questions in the survey. (See Additional File 2.) The comparison 
of reduced models 1 and 2 allows one to compare the relative amount of 
explained variance in consent choices that would be attributable to (a) 
health condition and (b) the combination of perceptions of medical benefit 
and disclosure concern.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1472-
6939-10-10-S4.doc]